Spontaneous interferon-alpha antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas

Ann Hematol. 1991 Feb-Mar;62(2-3):76-80. doi: 10.1007/BF01714905.

Abstract

High-titered spontaneous interferon (IFN) antibodies were detected in a patient with pure red cell aplasia (PRCA), a benign mediastinal tumor, and recurrent cutaneous carcinomas. The circulating IFN antibodies reacted broadly with various human IFN-alpha subtypes (20-140 x 10(3) neutralizing units/ml serum) but not with IFN-beta or IFN-gamma, and they neutralized the antiviral activity of the patient's endogenous IFN-alpha. The IFN-alpha-binding activity was restricted to the IgG1 subclass in a nonmonoclonal manner. Whereas the PRCA repeatedly responded to immunosuppression with high-dose cyclosporin A (CSA) and CSA plus plasmapheresis, IFN antibody production continued during treatment with cyclophosphamide and CSA. Serological analysis revealed past infection with parvovirus B19 and persistent B19 IgM titers. Antibody-mediated impairment of the IFN-alpha system might have favored the development of both PRCA and the various cutaneous carcinomas in this patient.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Autoantibodies / blood*
  • Cyclophosphamide / therapeutic use
  • Cyclosporins / therapeutic use
  • Humans
  • Immunosuppression Therapy
  • Interferon Type I / immunology*
  • Male
  • Plasmapheresis
  • Red-Cell Aplasia, Pure / immunology*
  • Red-Cell Aplasia, Pure / therapy
  • Skin Neoplasms / immunology*
  • Skin Neoplasms / surgery

Substances

  • Autoantibodies
  • Cyclosporins
  • Interferon Type I
  • Cyclophosphamide